J Korean Ster Func Neurosurg.
2022 Sep;18(2):103-106. 10.52662/jksfn.2022.00241.
Total intravenous anesthesia with remimazolam in a patient with epilepsy who underwent deep brain stimulation: a case report
- Affiliations
-
- 1Department of Neurology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
- 2Department of Anesthesiology and Pain Medicine, Wonju Severance Christian Hospital, Wonju, Korea
- 3Department of Anesthesiology and Pain Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
- KMID: 2534600
- DOI: http://doi.org/10.52662/jksfn.2022.00241
Abstract
- Drugs administered for anesthesia can trigger seizure attacks in patients with epilepsy. Benzodiazepines have been consistently reported to be anticonvulsants, and a novel benzodiazepine, remimazolam, was recently introduced. We report a case of total intravenous anesthesia maintained with remimazolam in a patient with epilepsy who underwent deep brain stimulation of both anterior thalamic nuclei. Despite the administration of multiple anti-epileptic drugs, no tolerance to remimazolam was observed. Perioperative seizures were also not observed. Remimazolam can be considered the anesthetic of choice in patients with epilepsy.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Patient-controlled sedation using remimazolam during third molar extraction: a case report
- Deep Brain Stimulation for the Treatment of Medically Intractable Epilepsy: a Review on Clinical Application
- Neurostimulation for Epilepsy Treatment
- Remimazolam – current knowledge on a new intravenous benzodiazepine anesthetic agent
- Comparison of postoperative nausea and vomiting between remimazolam and propofol: a propensity score-matched, retrospective, observational, single-center cohort study
